<DOC>
	<DOCNO>NCT00421135</DOCNO>
	<brief_summary>The study safety Isophosphoramide Mustard ( IPM ) treatment advanced cancer .</brief_summary>
	<brief_title>A Protocol Safety Tolerance Intravenous Isophosphoramide Mustard ( IPM ) Patients With Advanced Cancer</brief_title>
	<detailed_description />
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Isophosphamide mustard</mesh_term>
	<mesh_term>Ifosfamide</mesh_term>
	<criteria>Metastatic /or unresectable disease state previous standard chemotherapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2009</verification_date>
</DOC>